• Join Our Team
  • Contact Us
McDermott + Bull - Executive Search + Interim Leaders
  • INDUSTRIES
    • Arts + Culture, Education, + Nonprofit
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Energy + Sustainability
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • SERVICES
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • ABOUT M+B
    • Our Team
  • INSIGHTS
Select Page
  • Contact Us
  • Services
    • Executive Search
    • Interim Leaders
    • Performance Coaching
  • Industries
    • Aviation, Aerospace, + Defense
    • Consumer Brands
    • Arts + Culture, Education, + Nonprofit
    • Energy + Sustainability
    • Essential Services
    • Financial Services
    • Healthcare + Life Sciences
    • Industrial, Manufacturing, + Distribution
    • Private Equity
    • Real Estate
    • Technology
  • About M+B
    • Our Team
    • Diversity
  • Insights
  • Join Us
McDermott + Bull Places Chief Financial Officer at Adherium

McDermott + Bull Places Chief Financial Officer at Adherium

by McDermott + Bull | Nov 13, 2026 | Placement Announcement, Dani Rone, Ken Dropiewski, Ken Dropiewski Placement Announcement

McDermott + Bull has successfully placed Bradley Wilson as Chief Financial Officer at Adherium. In his role, Bradley will lead financial strategy, capital planning, and financial operations as the company expands its U.S. presence. He will partner closely with the...
McDermott + Bull Places Jeffrey DellaFranco as Vice President of Sales at Galvanize Therapeutics

McDermott + Bull Places Jeffrey DellaFranco as Vice President of Sales at Galvanize Therapeutics

by McDermott + Bull | Sep 26, 2026 | Ken Dropiewski, Dani Rone, Ken Dropiewski Placement Announcement

McDermott + Bull has successfully placed Jeffrey DellaFranco as Vice President of Sales at Galvanize Therapeutics. In this role, Jeff will lead the company’s U.S. sales organization and support its transition to a procedure-focused commercial model. He will focus on...
McDermott + Bull Places Rhonda Robb as Chief Executive Officer at ArchCath

McDermott + Bull Places Rhonda Robb as Chief Executive Officer at ArchCath

by McDermott + Bull | Sep 22, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga

McDermott + Bull has successfully placed Rhonda Robb as Chief Executive Officer at ArchCath. In this role, Rhonda will lead the company through its next phase of growth, with responsibility for advancing its financing, clinical, regulatory, and commercialization...
The Silent Multiplier: Why Your Best Hire Might Be Your #2

The Silent Multiplier: Why Your Best Hire Might Be Your #2

by McDermott + Bull | Sep 21, 2026 | Article, Ken Dropiewski, Ken Dropiewski Article

Most CEOs I work with are exceptional at vision. They can articulate where the company is going, why it matters, and what winning looks like. What they struggle to articulate is why they’re still approving vendor contracts, resolving team conflicts, and sitting...
Investor Insights: Ken Dropiewski with Jan Garfinkle + Jeff Terrell

Investor Insights: Ken Dropiewski with Jan Garfinkle + Jeff Terrell

by McDermott + Bull | Aug 24, 2026 | Ken Dropiewski, Investor Insights, Video

McDermott + Bull Partner Ken Dropiewski sits down with Jan Garfinkle, Founder & Managing Partner of Arboretum Ventures, and Jeff Terrell, Managing Partner, to discuss their perspectives on healthcare investing and the evolving venture capital landscape. Jan shares...
McDermott + Bull Places David Vort as Chief Commercial Officer at Caristo Diagnostics

McDermott + Bull Places David Vort as Chief Commercial Officer at Caristo Diagnostics

by McDermott + Bull | Aug 11, 2026 | Ken Dropiewski, Ken Dropiewski Placement Announcement, Michael Matranga

McDermott + Bull has successfully placed David Vort as Chief Commercial Officer at Caristo Diagnostics. In this role, David will lead the company’s U.S. commercial strategy, with responsibility for accelerating revenue, advancing market access and reimbursement...
« Older Entries

Recent Posts

  • Netlist Appoints James Hickey to Its Board of Directors
  • McDermott + Bull Places Controller at American Friends of Magen David Adom (AFMDA)
  • Paul Gibbons Featured in Hunt Scanlon’s 2026 Canada Recruiting Report
  • McDermott + Bull Launches Two Senior Fundraising Searches for Success Academy Charter Schools
  • McDermott + Bull Places Chief Financial Officer at Adherium

Categories

Copyright 2026 McDermott + Bull, Inc. All rights reserved.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policy